Patients who undergo allogeneic stem cell transplantation frequently develop an immunologic disease caused by the reactivation of the graft to the host tissues. This disease is called graft-versus-host disease (GVHD) and it is usually a systemic disorder. In a large proportion of cases, oral disorders that are related to a chronic phase of GVHD (cGVHD) occur, and their treatment involves the use of topical immunosuppressive drugs. Several medications have been studied for this purpose, but only a small number of clinical trials have been published. The present study is a randomized, double-blind clinical trial that compares topical clobetasol and dexamethasone for the treatment of symptomatic oral cGVHD. Patients were randomly assigned to treatment with clobetasol propionate .05% or dexamethasone .1 mg/mL for 28 days. In both arms, nystatin 100,000 IU/mL was administered with the corticosteroid. Oral lesions were evaluated by the modified oral mucositis rating scale (mOMRS) and symptoms were registered using a visual analogue scale. Thirty-five patients were recruited, and 32 patients were randomized into the study groups: 18 patients (56.3%) to the dexamethasone group and 14 patients (43.8%) to the clobetasol group. The use of clobetasol resulted in a significant reduction in mOMRS total score (P = .04) and in the score for ulcers (P = .03). In both groups, there was significant symptomatic improvement but the response was significantly greater in the clobetasol group (P = .02). In conclusion, clobetasol was significantly more effective than dexamethasone for the amelioration of symptoms and clinical aspects of oral lesions in cGVHD. © 2014 American Society for Blood and Marrow Transplantation.20811631168Filipovich, A.H., Weisdorf, D., Pavletic, S., National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report (2005) Biol Blood Marrow Transplant, 11, pp. 945-956Pereira, C.M., de Almeida, O.P., Correa, M.E., Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients (2007) Gen Dent, 55, pp. 48-51Schubert, M.M., Correa, M.E., Oral graft-versus-host disease (2008) Dent Clin North Am, 52, pp. 79-109Noce, C.W., Gomes, A., Copello, A., Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients (2011) Gen Dent, 59, pp. 458-462Niissalo, S., Hampf, G., Hietanen, J., Thermal sensation and pain in oral lichen planus and lichenoid reaction (2003) J Oral Pathol Med, 32, pp. 41-45Boer, C.C., Correa, M.E., Miranda, E.C., de Souza, C.A., Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT (2010) Bone Marrow Transplant, 45, pp. 705-711Inamoto, Y., Martin, P.J., Chai, X., Clinical benefit of response in chronic graft-versus-host disease (2012) Biol Blood Marrow Transplant, 18, pp. 1517-1524Busca, A., Locatelli, F., Marmont, F., Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease (2003) Haematologica, 88, pp. 837-839Huang, X.J., Jiang, Q., Chen, H., Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation (2005) Bone Marrow Transplant, 36, pp. 343-348Albert, M.H., Becker, B., Schuster, F.R., Oral graft vs. host disease in children-treatment with topical tacrolimus ointment (2007) Pediatr Transplant, 11, pp. 306-311Eckardt, A., Starke, O., Stadler, M., Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus (2004) Oral Oncol, 40, pp. 811-814Elad, S., Or, R., Garfunkel, A.A., Shapira, M.Y., Budesonide: a novel treatment for oral chronic graft versus host disease (2003) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 95, pp. 308-311Elad, S., Zeevi, I., Finke, J., Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study (2012) Biol Blood Marrow Transplant, 18, pp. 134-140Epstein, J.B., Nantel, S., Sheoltch, S.M., Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease (2000) Bone Marrow Transplant, 25, pp. 683-687Epstein, J.B., Gorsky, M., Epstein, M.S., Nantel, S., Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases (2001) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91, pp. 56-61Fricain, J.C., Sibaud, V., Swetyenga, N., Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease (2007) Br J Dermatol, 156, pp. 588-590Mawardi, H., Stevenson, K., Gokani, B., Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD (2010) Bone Marrow Transplant, 45, pp. 1062-1067Schlaak, M., Treudler, R., Colsman, A., Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus (2008) J Eur Acad Dermatol Venereol, 22, pp. 112-113Wolff, D., Anders, V., Corio, R., Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease (2004) Photodermatol Photoimmunol Photomed, 20, pp. 184-190Sari, I., Altuntas, F., Kocyigit, I., The effect of budesonide mouthwash on oral chronic graft versus host disease (2007) Am J Hematol, 82, pp. 349-356Hengge, U.R., Ruzicka, T., Schwartz, R.A., Cork, M.J., Adverse effects of topical glucocorticosteroids (2006) J Am Acad Dermatol, 54, pp. 1-15Naumann, L., Feist, E., Straub, R.H., Potencies of topical glucocorticoids to mediate genomic and nongenomic effects on human peripheral blood mononuclear cells (2006) Biochem Pharmacol, 71, pp. 530-539Gonzalez-Moles, M.A., Ruiz-Avila, I., Rodriguez-Archilla, A., Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays (2003) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 95, pp. 688-692Jajarm, H.H., Falaki, F., Mahdavi, O., A comparative pilot study of low intensity laser versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus (2011) Photomed Laser Surg, 29, pp. 421-425Pai, S., Ghezzi, E.M., Ship, J.A., Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction (2001) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91, pp. 311-316Baharvand, M., Sarrafi, M., Alavi, K., Jalali Moghaddam, E., Efficacy of topical phenytoin on chemotherapy-induced oral mucositisa pilot study (2010) Daru, 18, pp. 46-50Pavletic, S.Z., Martin, P., Lee, S.J., Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report (2006) Biol Blood Marrow Transplant, 12, pp. 252-266Tiwana, M.S., Mahajan, M.K., Uppal, B., Whole saliva physico-biochemical changes and quality of life in head and neck cancer patients following conventional radiation therapy: a prospective longitudinal study (2011) Indian J Cancer, 48, pp. 289-295Torres, S.R., Peixoto, C.B., Caldas, D.M., Relationship between salivary flow rates and Candida counts in subjects with xerostomia (2002) Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 93, pp. 149-154Marton, K., Madlena, M., Banoczy, J., Unstimulated whole saliva flow rate in relation to sicca symptoms in Hungary (2008) Oral Dis, 14, pp. 472-477Couriel, D., Carpenter, P.A., Cutler, C., Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report (2006) Biol Blood Marrow Transplant, 12, pp. 375-396Carbone, M., Arduino, P.G., Carrozzo, M., Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations (2009) J Oral Pathol Med, 38, pp. 227-233Motta, A.C., Domaneschi, C., Komesu, M.C., Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis (2009) Braz Dent J, 20, pp. 231-236Fu, J., Zhu, X., Dan, H., Amlexanox is as effective as dexamethasone in topical treatment of erosive oral lichen planus: a short-term pilot study (2012) Oral Surg Oral Med Oral Pathol Oral Radiol, 113, pp. 638-643Park, A.E., La, H.O., Cho, B.S., Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease (2013) Am J Health-Syst Pharm, 70, pp. 1383-1391Imanguli, M.M., Atkinson, J.C., Mitchell, S.A., Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation (2010) Biol Blood Marrow Transplant, 16, pp. 1362-1369Gomes, A.O., Torres, S.R., Maiolino, A., Early and late oral features of chronic graft-versus-host disease (2014) Rev Bras Hematol Hemoter, 36, pp. 43-49Varoni, E.M., Molteni, A., Sardella, A., Pharmacokinetics study about topical clobetasol on oral mucosa (2012) J Oral Pathol Med, 41, pp. 255-260Shojaei, A.H., Buccal mucosa as a route for systemic drug delivery: a review (1998) J Pharm Pharm Sci, 1, pp. 15-30